Dose-related Research Gaps
Research gap analysis derived from 2 medicine papers in our local library.
The gap
Optimal dosing strategies for antipsychotics in elderly and renal-impaired patients need to be established through specific dose escalation schedules and clearance adjustment formulas.
Consensus across the literature
The papers collectively establish the importance of cautious dose initiation but leave open the specific protocols for elderly and renal-impaired populations.
Research trend
Emerging — attention growing, methods still coalescing.
Supporting evidence — 2 representative gaps
- Aspirin's Dual Role in Cancer: A Systematic Review of the Current Evidence (2026) · doi
Higher doses (≥300 mg/day) have not consistently demonstrated superior anticancer benefits in randomized trials, and the reasons for dose-response variations are unclear.
Keywords: higher doses consistently superior anticancer benefits randomized trials reasons dose response variations unclear - Efficacy and safety of oral doxycycline for acne vulgaris treatment: A systematic review and meta-analysis (2026) · doi
2016), was observed in some trials, yet the optimal dose and duration remain unclear.
Keywords: observed trials optimal dose duration remain unclear
Working on this gap? Publish with us.
Science AI Journal reviews manuscripts in under 15 minutes with 8 specialised AI reviewers calibrated on 23,000+ real peer reviews. Open access, CC BY 4.0.
Related gaps in medicine
- Diagnostic and Prognostic MarkersFurther validation is needed to establish standardized criteria for MRI and sonoelastography in differentiating phyllodes tumors from fibroa…
- Research Method ValidationFurther validation of AI systems and biomarkers is needed across diverse clinical settings and patient populations to ensure safe and effect…
- Validation Across ConditionsFurther studies are needed to confirm the reproducibility and effectiveness of proposed methods under different conditions, including full-s…
- Generalizability of FindingsMost studies lack external validation in diverse populations or settings, questioning the generalizability of their findings.